Zhao L - Search Results

1

Response to letter regarding article, “histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid”.

Zhao L, Chen CN, Hajji N, Oliver E, Cotroneo E, Wharton J, Wilkins MR, Wang D, Li M, Stenmark KR, McKinsey TA, Buttrick P. Zhao L, et al. Circulation. 2013 Apr 9;127(14):e540. doi: 10.1161/circulationaha.112.154757. Circulation. 2013. PMID: 23691553 No abstract available.

2

The regulation of pulmonary vascular tone.

Wilkins MR, Zhao L, al-Tubuly R. Wilkins MR, et al. Among authors: zhao l. Br J Clin Pharmacol. 1996 Jul;42(1):127-31. doi: 10.1046/j.1365-2125.1996.37117.x. Br J Clin Pharmacol. 1996. PMID: 8807153 Free PMC article. Review.

3

NPR-A-Deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension.

Zhao L, Long L, Morrell NW, Wilkins MR. Zhao L, et al. Circulation. 1999 Feb 9;99(5):605-7. doi: 10.1161/01.cir.99.5.605. Circulation. 1999. PMID: 9950655

4

Right ventricular hypertrophy secondary to pulmonary hypertension is linked to rat chromosome 17: evaluation of cardiac ryanodine Ryr2 receptor as a candidate.

Zhao L, Sebkhi A, Nunez DJ, Long L, Haley CS, Szpirer J, Szpirer C, Williams AJ, Wilkins MR. Zhao L, et al. Circulation. 2001 Jan 23;103(3):442-7. doi: 10.1161/01.cir.103.3.442. Circulation. 2001. PMID: 11157698

5

Sildenafil inhibits hypoxia-induced pulmonary hypertension.

Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR. Zhao L, et al. Circulation. 2001 Jul 24;104(4):424-8. doi: 10.1161/hc2901.093117. Circulation. 2001. PMID: 11468204 Clinical Trial.

6

Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.

Zhao L, Mason NA, Strange JW, Walker H, Wilkins MR. Zhao L, et al. Circulation. 2003 Jan 21;107(2):234-7. doi: 10.1161/01.cir.0000050653.10758.6b. Circulation. 2003. PMID: 12538421

7

Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.

Khoo JP, Zhao L, Alp NJ, Bendall JK, Nicoli T, Rockett K, Wilkins MR, Channon KM. Khoo JP, et al. Among authors: zhao l. Circulation. 2005 Apr 26;111(16):2126-33. doi: 10.1161/01.CIR.0000162470.26840.89. Epub 2005 Apr 11. Circulation. 2005. PMID: 15824200

8

Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.

Baliga RS, Zhao L, Madhani M, Lopez-Torondel B, Visintin C, Selwood D, Wilkins MR, MacAllister RJ, Hobbs AJ. Baliga RS, et al. Among authors: zhao l. Am J Respir Crit Care Med. 2008 Oct 15;178(8):861-9. doi: 10.1164/rccm.200801-121OC. Epub 2008 Aug 8. Am J Respir Crit Care Med. 2008. PMID: 18689467 Free PMC article.

9

Simvastatin and sildenafil combine to attenuate pulmonary hypertension.

Zhao L, Sebkhi A, Ali O, Wojciak-Stothard B, Mamanova L, Yang Q, Wharton J, Wilkins MR. Zhao L, et al. Eur Respir J. 2009 Oct;34(4):948-57. doi: 10.1183/09031936.00143508. Eur Respir J. 2009. PMID: 19797670 Free article.

10

[Future treatment of pulmonary arterial hypertension].

Wilkins MR, Zhao L. Wilkins MR, et al. Among authors: zhao l. Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2097-8. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20058610 Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,124 results

Search Page